Ian Sinclair
associate principal scientist
AstraZeneca, Discovery Sciences
Presentation(s):
-
An Introduction to Mass Spectrometry and its Applications within Drug Discovery
Sunday, February 4
12:00 PM – 3:15 PM
Short Courses
Ian Sinclair, BSc
associate principal scientist
AstraZeneca, Discovery Sciences
Jonathan Wingfield
Principle Scientist
AstraZeneca
This short course will provide an introduction to mass spectrometry and the range of potential applications within drug discovery. We will cover the basic principles of mass spectrometry including the differences between the array of ionization modalities and detectors available today. While mass spectrometry has contributed significantly to drug discovery, recent advances are enabling high throughput screening applications.
Additional fees apply. Visit http://www.slas2018.org/program/short-course-program/ for more information.
associate principal scientist
AstraZeneca, Discovery Sciences
An Introduction to Mass Spectrometry and its Applications within Drug Discovery
Sunday, February 4
12:00 PM – 3:15 PM
Principle Scientist
AstraZeneca
Joined AZ in 2000, as part of a team responsible for delivering automation solutions and technology in to the disease area teams post HTS. Was invited to establish a Lead Generation Automation team within Oncology and this evolved into a centralised biochemical screening team in 2006. The centralised team utilized leading-edge technology to deliver high-quality data to global projects, this included delivery of acoustic droplet ejection technology. When the Discovery Sciences function was established within AZ, I moved into a science role supporting biochemical SAR. I remain interested in landing technologies that can add value to our core business, one such example is the acoustic mass spectrometry collaboration between Labcyte and AZ. This project won the SLAS Innovation award (2015) and has generated a significant amount of external interest.
An Introduction to Mass Spectrometry and its Applications within Drug Discovery
Sunday, February 4
12:00 PM – 3:15 PM
The asset you are trying to access is locked. Please enter your access key to unlock.